CRNX EBITDA Margin

Crinetics Pharmaceuticals Inc · EBITDA Margin

CRNX logo

CRNX EBITDA Margin

Latest reported-1206.92%
CRNX EBITDA Margin (-1010.53% → -1206.92%)
High-resolution chart · PNG

CRNX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Crinetics Pharmaceuticals Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-5,993.3342%
-28,452.6468%
-5,318.4899%
-3,439.6242%
-9,899.7217%
-104,232.3944%
-4,437.9715%
-1,163.056%
-440.0489%
-1,010.5263%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.